Template 3: Complex Plan
SPECIAL REQUIREMENTS SECTION OF (Insert Application number) 1. Plans to share research resources. To the extent owned and controlled by Thomas Jefferson University (TJU), all vectors for transgenic production and mouse strains generated over the past several years have been distributed freely to the broader academic community, either before or immediately on publication. Indeed we have supplied over ____requesting laboratories with either vectors, mice, or both. Requestees typically receive the desired reagents within _______ months of their request, depending on their chronological position in the queue. The infrastructure for this rapid sharing of newly developed reagents (both vectors and mice) continues to be in place in my lab and supported by the TJU Office of Technology Transfer (letter attached). 2. Intellectual property rights. Consistent with TJU’s policy on intellectual property rights, and to the extent owned and controlled by TJU, my lab will make available any and all strains of transgenic mice produced under this grant for use at other academic or not-for-profit institutions at no cost except for standard maintenance and transportation expenses. TJU will reserve the right to use these reagents for educational, research, or other nonbusiness purposes. TJU may establish a non-exclusive commercial license granting TJU’s rights to use such animals at specific for-profit entities; in these cases, TJU will maintain the right to grant non-exclusive licenses for use of these materials by academic or not-for-profit institutions. Transfer of materials to not-for-profit entities will be implemented under terms no more restrictive than the Uniform Biological Materials Transfer Agreement (UBMTA) (see example of the UBMTA attached in the appendix). Transfer of materials to forprofit entities will be mediated through the TJU Office of Technology Transfer, and typically involves a simple license agreement with execution or annual fees as deemed appropriate, but in no way prohibitive to the ready distribution of these reagents. (Non-Profit) Intellectual property rights as pertains to _________ reagent(s): ______________ holds a patent on the use of ABC in mammalian cells. They have made clear that any reagents harboring _______or _______sequences can be freely distributed amongst academic, not-for-profit institutions. Such transfers would be done under a joint simple MTA between TJU and _____________________. Should reagents be transferred to for-profit institutions, an inter-institutional license between TJU and____________________ will be drafted with execution or annual fees as deemed appropriate, but in no way prohibitive to the ready distribution of these reagents. Those reagents generated
in collaboration with Dr. ____________ at _______________would require an inter-institutional MTA involving TJU and ______________________. (For-profit) Intellectual property rights as pertains to __________reagents: _______________ holds a patent on the use of ________in__________. The memorandum of understanding between ____________________and PHS makes it clear that any and all ________- containing reagents generated under this grant can be readily shared with the broader academic community under a simple MTA, and do not infringe on the uses under restriction (namely: _____________) Should our reagents be transferred to for-profit institutions, an inter-institutional license between TJU and ___________________ will be drafted with execution or annual fees as deemed appropriate. Of course, current _______________ licensing issues as surrounds for-profit institutions would have to be settled between that institution and _____________ Company. Intellectual property rights as pertains to the _______ locus: _______________________ holds a license on use of ___________sequences. This license stipulates free use for academic, not-for-profit institutions and involves a simple MTA. Those reagents generated in collaboration with Dr. ____________ at ________________that incorporate ___________ sequences will require an inter-institutional MTA involving TJU and _________________. Should reagents be transferred to for-profit institutions, an inter-institutional license between TJU and ____________________ will be drafted with execution or annual fees as deemed appropriate, but in no way prohibitive to the ready distribution of these reagents.